" /> Anti-CD3/Anti-BCMA Bispecific Antibody TQB2934 - CISMeF





Preferred Label : Anti-CD3/Anti-BCMA Bispecific Antibody TQB2934;

NCIt synonyms : Anti-CD3 x BCMA Double-specific Antibody TQB2934; Anti-BCMA/Anti-CD3 Bispecific Antibody TQB2934; Anti-CD3/Anti-BCMA T-cell Engaging Bispecific Antibody TQB2934; Anti-CD3/BCMA Bispecific Antibody TQB2934; Bispecific Antibody TQB2934;

NCIt definition : A T-cell engaging, human, bispecific, immunoglobulin G1 (IgG1) monoclonal antibody directed against the tumor-associated antigen (TAA) human B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily member 17; TNFRSF17) and CD3 antigen found on T-lymphocytes, with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD3/anti-BCMA bispecific antibody TQB2934 binds to both CD3 on cytotoxic T-lymphocytes (CTLs) and BCMA found on BCMA-expressing tumor cells. This activates and redirects CTLs to BCMA-expressing tumor cells, which results in the CTL-mediated cell death of BCMA-expressing tumor cells. BCMA, a member of the tumor necrosis factor receptor superfamily that is specifically overexpressed on malignant plasma cells, plays a key role in promoting plasma cell survival.;

Molecule name : TQB-2934; TQB 2934;

NCI Metathesaurus CUI : CL1906247;

Details


You can consult :


Nous contacter.
28/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.